Adverts

Open Access Articles- Top Results for TFMFly

TFMFly

</th></tr>
TFMFly
200px
Systematic (IUPAC) name
(2R)-1-(8-trifluoromethyl-2,3,6,7-tetrahydrobenzo[1,2-b:4,5-b’]difuran-4-yl)-2-aminoethane
Clinical data
Identifiers
780744-19-6 7pxY
332012-20-1 (hydrochloride)
PubChem CID 10782206
Chemical data
Formula C14H16F3NO2
287.277 g/mol
 14pxY (what is this?)  (verify)

TFMFly is a compound related to psychedelic phenethylamines such as 2C-B-FLY and 2C-TFM. It was first reported in 2005 by a team at Purdue University led by David Nichols.[1] It acts as a potent agonist at the 5HT2A serotonin receptor subtype, and is a chiral compound with the more active (R) enantiomer having a Ki of 0.12nM at the human 5HT2A receptor.[2] While the fully aromatic benzodifurans such as bromodragonfly generally have higher binding affinity than saturated compounds like 2C-B-FLY,[3] the saturated compounds have higher efficacy as agonists.[4]

References

  1. ^ Michael Robert Braden PhD. Towards a biophysical understanding of hallucinogen action. Purdue University 2007.
  2. ^ Parrish JC; Braden MR; Gundy E; Nichols DE (December 2005). "Differential phospholipase C activation by phenylalkylamine serotonin 5-HT 2A receptor agonists". Journal of Neurochemistry 95 (6): 1575–84. PMID 16277614. doi:10.1111/j.1471-4159.2005.03477.x. 
  3. ^ Chambers JJ; Kurrasch-Orbaugh DM; Parker MA; Nichols DE (March 2001). "Enantiospecific synthesis and pharmacological evaluation of a series of super-potent, conformationally restricted 5-HT(2A/2C) receptor agonists". Journal of Medicinal Chemistry 44 (6): 1003–10. PMID 11300881. doi:10.1021/jm000491y. 
  4. ^ Ralf Heim PhD. Synthese und Pharmakologie potenter 5-HT2A-Rezeptoragonisten mit N-2-Methoxybenzyl-Partialstruktur. Entwicklung eines neuen Struktur-Wirkungskonzepts. (German)


Lua error in package.lua at line 80: module 'Module:Buffer' not found.